Literature DB >> 16252138

Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma.

B Duncan X Lascelles1, William S Dernell, Maria T Correa, Mary Lafferty, Chad M Devitt, Charles A Kuntz, Rodney C Straw, Stephen J Withrow.   

Abstract

BACKGROUND: Limb-salvage surgery and adjuvant chemotherapy are performed as a treatment of appendicular osteosarcoma in dogs. Approximately 50% of dogs that undergo limb-salvage surgery develop postoperative surgical wound infections. Postoperative surgical infections may affect survival in cancer patients. The purposes of this study were to examine the effect of surgical wound infection on survival, local recurrence, and metastasis in relation to other prognostic factors for dogs with spontaneous osteosarcoma treated with limb-salvage surgery.
METHODS: Forty-seven client-owned dogs with osteosarcoma of the distal radius were treated with limb-salvage surgery and adjuvant chemotherapy--either carboplatin or carboplatin and doxorubicin. Hazard ratios were estimated by using the Cox proportional hazard model, and survival functions were estimated by using the Kaplan-Meier product-limit life-table method.
RESULTS: Of the 47 dogs in this study, 32 (68%) developed a postoperative wound infection. Infection, dog weight, and extent of the primary tumor (percentage of length) significantly affected survival, and infection and percentage of length significantly affected time to metastasis. None of the variables considered in this study affected local recurrence. Dogs that were diagnosed with an infection were less likely to die (hazard ratio, .446), and dogs with greater body weight and greater percentage length involvement were more likely to die (hazard ratios of 3.37 and 3.66, respectively).
CONCLUSIONS: In dogs with osteosarcoma treated with limb-salvage surgery, infection has a positive influence on survival, as does a smaller initial length of radius involved and lower body weight.

Entities:  

Mesh:

Year:  2005        PMID: 16252138     DOI: 10.1245/ASO.2005.01.011

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  43 in total

1.  Limb-sparing surgery using tantalum metal endoprosthesis in a dog with osteosarcoma of the distal radius.

Authors:  Tamara L MacDonald; Teresa D Schiller
Journal:  Can Vet J       Date:  2010-05       Impact factor: 1.008

2.  Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.

Authors:  P M Anderson; P Meyers; E Kleinerman; K Venkatakrishnan; D P Hughes; C Herzog; W Huh; R Sutphin; Y M Vyas; V Shen; A Warwick; N Yeager; C Oliva; B Wang; Y Liu; A Chou
Journal:  Pediatr Blood Cancer       Date:  2013-08-31       Impact factor: 3.167

3.  What's new in orthopedics.

Authors:  Greg Harasen
Journal:  Can Vet J       Date:  2007-02       Impact factor: 1.008

4.  Molecular biology and therapeutics in musculoskeletal oncology.

Authors:  Theresa A Guise; Regis O'Keefe; R Lor Randall; Richard M Terek
Journal:  J Bone Joint Surg Am       Date:  2009-03-01       Impact factor: 5.284

5.  Immune dysregulation and osteosarcoma: Staphylococcus aureus downregulates TGF-β and heightens the inflammatory signature in human and canine macrophages suppressed by osteosarcoma.

Authors:  Joanne L Tuohy; Jason A Somarelli; Luke B Borst; William C Eward; B Duncan X Lascelles; Jonathan E Fogle
Journal:  Vet Comp Oncol       Date:  2019-10-15       Impact factor: 2.613

6.  Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.

Authors:  K A Skorupski; J M Uhl; A Szivek; S D Allstadt Frazier; R B Rebhun; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-10-04       Impact factor: 2.613

7.  Highly metastatic K7M2 cell line: A novel murine model capable of in vivo imaging via luciferase vector transfection.

Authors:  Brian T Grisez; Justin J Ray; Phillip A Bostian; Justin E Markel; Brock A Lindsey
Journal:  J Orthop Res       Date:  2018-02-10       Impact factor: 3.494

8.  Treatment of extraskeletal osteosarcoma at a previous injection site resulting in prolonged survival in 1 dog.

Authors:  Laura E Selmic; Lynn R Griffin; Megan H Rector; Mary Lafferty; Roy Pool; Nicole P Ehrhart
Journal:  Can Vet J       Date:  2016-09       Impact factor: 1.008

9.  Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival.

Authors:  Agneta Egenvall; Ane Nødtvedt; Henrik von Euler
Journal:  Can J Vet Res       Date:  2007-10       Impact factor: 1.310

Review 10.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.